• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SABER035 5MM20CM 135 CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SABER035 5MM20CM 135 CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number 48005020R
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/01/2021
Event Type  malfunction  
Manufacturer Narrative
As reported, the balloon protection cover could not be removed during the prep of a saber 035 5mm x 20cm 135cm. After several attempts to remove, the balloon could not be used for the procedure. Also noted, a separation of the body/shaft occurred due to the balloon cover removal difficulty. The balloon was never in contact with the patient. There was no reported injury to the patient. The product was stored properly according to the instructions for use (ifu). There was no difficulty removing the device from the hoop, stylet and/or removing any of the sterile packaging components. The device was prepped normally and was able to maintain negative pressure. Besides the balloon cover difficulty, no difficulty was noted during prep. There was no damage to the actual balloon. One product was returned for analysis. A non-sterile saber035 5mm x 20cm 135 was received for analysis coiled inside a plastic bag. Per visual analysis, the balloon was observed still covered in its protective balloon cover. Also, the body/shaft of the unit was observed separated as received. No other anomalies were observed. The protective balloon cover was withdrawn/removed from the balloon with no difficulty. Per sem analysis on the separated body/shaft, results showed that the separation on the body/shaft presented evidence of elongations and a flared condition on the body/shaft material. The elongations and flared condition are commonly associated with separations caused by material tensile overload. Therefore, it is assumed that the body/shaft material was induced to a tensile force/pulling event that exceeded the body/shaft material yield strength prior to the separation. No other anomalies were observed during sem analysis. A product history record (phr) review of lot 82198018 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event. The reported ¿packaging/pouch/box - removal difficulty - protective balloon cover (balloon catheters)¿ was not confirmed since the protective balloon cover was withdrawn/removed from the balloon with no difficulty. The reported "body/shaft - separated - during prep" was confirmed since the body/shaft of the unit was observed separated as received. The exact cause of the reported event cannot be determined. Device analysis revealed the body/shaft of the unit was elongated and flared. Thus, indicating the device was induced to forces exceeding its material yield strength prior to the separation. Procedural factors and handling of the device during preparation likely contributed to the events as evidenced by device analysis. According to the device description in the safety information in the instructions for use ¿prepare an angioplasty inflation system with a 50% solution of contrast medium in sterile saline or similar solution. Without twisting, slide the forming tube off the balloon. Prepare an angioplasty inflation system with a 50% solution of contrast medium in sterile saline or similar solution. Place the prepared catheter over a prepositioned guidewire and advance the tip to the introduction site. Note: balloon inflation should be performed with the guidewire extended beyond the catheter tip. It is strongly recommended that the guidewire, the balloon catheter, or both, remain across the lesion until the procedure is complete and the dilatation system is to be removed from the vessel. Note: to preserve the folded balloon shape during insertion and catheter manipulation, maintain a vacuum on the inflation lumen. Caution: fully deflate the balloon by inducing negative pressure with the inflation system whenever the pta catheter is advanced or withdrawn. Do not advance or withdraw the pta catheter within the vasculature unless the catheter is preceded by a guidewire. Carefully advance the catheter through a sheath or guide catheter through the percutaneous entry site. Note: gentle counterclockwise rotation of the balloon may ease introduction through the sheath or percutaneous entry site. Note: perform all further catheter manipulations under fluoroscopy. Carefully advance the catheter to the selected stenosis. Caution: if strong resistance is met during advancement or withdrawal of the catheter, discontinue movement and determine the cause of resistance before proceeding. If the cause of resistance cannot be determined, withdraw the entire system¿ neither the phr nor the information available suggests a design or manufacturing related cause for the reported event. Therefore, no corrective or preventive action will be taken at this time.
 
Event Description
As reported, the balloon protection cover could not be removed during the prep of a saber (035) 5mm 20cm 135cm. After several attempts to remove, the balloon could not be used for the procedure. Also noted, a separation of the body/shaft occurred due to the balloon cover removal difficulty. The balloon was never in contact with the patient. There was no reported injury to the patient. The product was stored properly according to the instructions for use (ifu). There was no difficulty removing the device from the hoop, stylet and/or removing any of the sterile packaging components. The device was prepped normally and was able to maintain negative pressure. Besides the balloon cover difficulty, no difficulty was noted during prep. There was no damage to the actual balloon. The device will be sent back for evaluation. Separation found during product evaluation and verified through additional information received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSABER035 5MM20CM 135
Type of DeviceCATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
14201 nw 60 avenue
miami lakes, FL 33014
7863138372
MDR Report Key13026822
MDR Text Key290449961
Report Number9616099-2021-05203
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeAU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/17/2021
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received12/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Model Number48005020R
Device Catalogue Number48005020R
Device Lot Number82198018
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/25/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/28/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-